Dominant papillary subtype is a significant predictor of the response to gefitinib in adenocarcinoma of the lung.

Source:http://linkedlifedata.com/resource/pubmed/id/15534107

Clin. Cancer Res. 2004 Nov 1 10 21 7311-7

Download in:

View as

General Info

PMID
15534107